Ignite Creation Date:
2024-05-06 @ 4:35 PM
Last Modification Date:
2024-10-26 @ 2:13 PM
Study NCT ID:
NCT05033691
Status:
RECRUITING
Last Update Posted:
2021-09-05
First Post:
2021-07-04
Brief Title:
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
Sponsor:
Hadassah Medical Organization
Organization:
Hadassah Medical Organization
Organization Data
Organization:
Hadassah Medical Organization
Class:
OTHER
Study ID:
LUNG-OSIME-SRS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Hadassah Medical Organization
Lead Sponsor Class:
OTHER
Responsible Party:
MEIRROVITZ AMICHAY
Responsible Party Title:
Principle investigator oncologist and radiation specialist
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Hadassah Medical Organization
Old Name:
None
Old Organization:
None